Biocon teams up with Sandoz for next-gen Biosimilars
| Jan 19, 2018, 01:28:10 PM | ET Now
Share
Biocon and Sandoz, the generic drug division of Novartis, have formed a partnership to develop, manufacture and sell affordable copies of biologic drugs in immunology and oncology globally.